These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC. Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651 [Abstract] [Full Text] [Related]
26. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung. Sikora J, Słodkowska J, Radomyski A, Giedronowicz D, Kobos J, Kupis W, Rudzinski P. Rocz Akad Med Bialymst; 1997 Dec; 42 Suppl 1():271-9. PubMed ID: 9337544 [Abstract] [Full Text] [Related]
27. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D. Lyu Z, Jin H, Yan Z, Hu K, Jiang H, Peng H, Zhuo H. Int J Mol Med; 2020 Oct; 46(4):1321-1334. PubMed ID: 32945351 [Abstract] [Full Text] [Related]
30. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer. Feng A, Tu Z, Yin B. Oncotarget; 2016 Apr 12; 7(15):20507-19. PubMed ID: 26840258 [Abstract] [Full Text] [Related]
31. Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation. Li Y, Zhao M, Guo C, Chu H, Li W, Chen X, Wang X, Li Y, Jia Y, Koussatidjoa S, Zhu F, Wang J, Wang X, Wang Q, Zhao W, Shi Y, Chen W, Zhang L. Oncogene; 2018 Feb 22; 37(8):1095-1106. PubMed ID: 29106392 [Abstract] [Full Text] [Related]
32. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Clin Cancer Res; 2000 Mar 22; 6(3):957-65. PubMed ID: 10741721 [Abstract] [Full Text] [Related]
33. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma. Ozbudak IH, Ozbilim G, Kucukosmanoglu I, Dertsiz L, Demircan A. Int J Surg Pathol; 2009 Oct 22; 17(5):390-5. PubMed ID: 18849317 [Abstract] [Full Text] [Related]
35. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion. Marwitz S, Depner S, Dvornikov D, Merkle R, Szczygieł M, Müller-Decker K, Lucarelli P, Wäsch M, Mairbäurl H, Rabe KF, Kugler C, Vollmer E, Reck M, Scheufele S, Kröger M, Ammerpohl O, Siebert R, Goldmann T, Klingmüller U. Cancer Res; 2016 Jul 01; 76(13):3785-801. PubMed ID: 27197161 [Abstract] [Full Text] [Related]
36. Isolated tumor endothelial cells maintain specific character during long-term culture. Matsuda K, Ohga N, Hida Y, Muraki C, Tsuchiya K, Kurosu T, Akino T, Shih SC, Totsuka Y, Klagsbrun M, Shindoh M, Hida K. Biochem Biophys Res Commun; 2010 Apr 16; 394(4):947-54. PubMed ID: 20302845 [Abstract] [Full Text] [Related]
37. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y. Eur J Cancer; 2014 Sep 16; 50(13):2336-50. PubMed ID: 25001183 [Abstract] [Full Text] [Related]